Patents Examined by Thurman K. Dage
  • S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
    Patent number: 6210706
    Abstract: The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of selegiline-responsive diseases and conditions. Diseases and conditions responsive to selegiline include those produced by neuronal degeneration or neuronal trauma and those due to immune system dysfunction. Effective dosages are a daily dose of at least about 0.015 mg/kg of body weight.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: April 3, 2001
    Assignee: Somerset Pharmaceuticals, Inc.
    Inventor: Anthony R. DiSanto